INTERACTION. New Modality Support (NMS) — a collaboration between Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital and GU Ventures, was established recently, with the mission to support the commercial development of research projects within the national drug development initiatives OligoNova and CCRM Nordic. Now, NMS takes important steps towards implementation. Västra Götaland Region (VGR), through its Environment and Regional Development Board, has contributed financial support to establish…
Engaging Study Visit with the Minister of Social Affairs and the National Life Science Office
COLLABORATION. The development of life science in Western Sweden is strategically driven by collaboration between universities, industry, and healthcare. During a study visit by Minister of Social Affairs Jakob Forssmed and Jeanette Edblad, Head of the National Life Science Office, representatives from institutions such as Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Chalmers University of Technology, AstraZeneca, and GoCo Health Innovation City presented the long-term vision for cooperation.…
Marit Stockfelt works as an international postdoc with ALF funding
GRANT. Marit Stockfelt, a doctor at Sahlgrenska University Hospital and researcher at the Institute of Medicine, is the first to receive ALF funding to complete a period as an international postdoc. The whole family is currently in the UK. Marit Stockfelt combines her ALF-funded research time at the Department of Rheumatology and Inflammation Research with work as a resident physician in Rheumatology at Sahlgrenska University Hospital. SLE and pregnancy Her…
Research Day 2024 featured inspiring presentations
COOPERATION. The presentations during the Research Day featured inspiration and laughter. The day provided insight into life-saving research on breast cancer, prostate cancer, stroke, thyroid disease and bipolar disorder. Sahlgrenska Academy Dean Jenny Nyström began by thanking the working group that organized the Research Day for their efforts: “Today’s program is great, about broad diseases affecting many patients and also society at large,” noted Jenny Nyström. This year’s Research Day…
Ten years later – major population study SCAPIS resumes
CONTINUATION OF STUDY. Over 30,000 randomly selected participants aged between 50 and 64 nationwide were examined when the SCAPIS study for cardiovascular and lung diseases began approximately ten years ago. Sahlgrenska University Hospital is leading the way as the second part of the study commences, with over 3,000 individuals from western Sweden being called to undergo follow-up examinations. “Now we know that a significant portion of Sweden’s population aged 50-64…